CrowdStrike Holdings, Inc. (CRWD) Stock Forecast
Data as of May 2, 2026Technology · Current price $456.75 (+2.49%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 10, 2026 | Meta Marshall | Morgan Stanley | $510.00 | +11.7% |
| Mar 4, 2026 | Peter Weed | Bernstein | $368.00 | -19.4% |
| Mar 4, 2026 | Dan Ives | Wedbush | $550.00 | +20.4% |
| Feb 26, 2026 | Rudy Kessinger | D.A. Davidson | $425.00 | -7.0% |
| Feb 13, 2026 | Stephen Bersey | HSBC | $446.00 | -2.4% |
| Jan 27, 2026 | Steve Koenig | Macquarie | $485.00 | +6.2% |
| Jan 9, 2026 | Rahul Chopra | Berenberg Bank | $600.00 | +31.4% |
| Jan 8, 2026 | Gregg Moskowitz | Mizuho Securities | $540.00 | +18.2% |
| Dec 18, 2025 | Meta Marshall | Morgan Stanley | $537.00 | +17.6% |
| Dec 11, 2025 | Almas Almaganbetov | Loop Capital Markets | $550.00 | +20.4% |
| Dec 3, 2025 | Gabriela Borges | Goldman Sachs | $564.00 | +23.5% |
| Dec 3, 2025 | Matthew Hedberg | RBC Capital | $621.00 | +36.0% |
| Dec 3, 2025 | Keith Bachman | BMO Capital | $555.00 | +21.5% |
| Dec 3, 2025 | Shyam Patil | Susquehanna | $600.00 | +31.4% |
| Dec 3, 2025 | Mike Cikos | Needham | $575.00 | +25.9% |
| Dec 3, 2025 | Rob Owens | Piper Sandler | $520.00 | +13.8% |
| Nov 25, 2025 | Rudy Kessinger | D.A. Davidson | $580.00 | +27.0% |
| Nov 14, 2025 | Saket Kalia | Barclays | $610.00 | +33.6% |
| Oct 28, 2025 | Ellie Bagshaw | Arete Research | $706.00 | +54.6% |
| Oct 17, 2025 | Ittai Kidron | Oppenheimer | $560.00 | +22.6% |
Top Analysts Covering CRWD
CRWD vs Sector & Market
| Metric | CRWD | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.22 | 2.34 | 2.41 |
| Analyst Count | 69 | 13 | 18 |
| Target Upside | +15.7% | +4072.7% | +14.9% |
| P/E Ratio | -627.31 | 28.74 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-01-31 | $5.90B | $5.91B | $5.96B | 37 |
| 2027-04-30 | $1.63B | $1.67B | $1.69B | 26 |
| 2027-07-31 | $1.71B | $1.74B | $1.77B | 19 |
| 2027-10-31 | $1.80B | $1.84B | $1.86B | 14 |
| 2028-01-31 | $1.90B | $1.94B | $1.97B | 13 |
| 2028-04-30 | $1.99B | $2.03B | $2.06B | 13 |
| 2028-07-31 | $2.07B | $2.11B | $2.14B | 22 |
| 2028-10-31 | $2.18B | $2.22B | $2.25B | 14 |
| 2029-01-31 | $2.30B | $2.34B | $2.38B | 15 |
| 2030-01-31 | $9.66B | $9.88B | $10.07B | 9 |
| 2031-01-31 | $11.26B | $11.51B | $11.73B | 10 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-01-31 | $4.83 | $4.87 | $4.95 | 28 |
| 2027-04-30 | $1.33 | $1.36 | $1.39 | 17 |
| 2027-07-31 | $1.43 | $1.47 | $1.50 | 21 |
| 2027-10-31 | $1.51 | $1.55 | $1.58 | 24 |
| 2028-01-31 | $1.69 | $1.73 | $1.76 | 26 |
| 2028-04-30 | $1.69 | $1.73 | $1.76 | 13 |
| 2028-07-31 | $1.85 | $1.89 | $1.93 | 13 |
| 2028-10-31 | $1.90 | $1.95 | $1.98 | 13 |
| 2029-01-31 | $2.17 | $2.22 | $2.26 | 12 |
| 2030-01-31 | $8.19 | $8.43 | $8.64 | 4 |
| 2031-01-31 | $9.62 | $9.90 | $10.15 | 3 |
Frequently Asked Questions
What is the analyst consensus for CRWD?
The consensus among 69 analysts covering CrowdStrike Holdings, Inc. (CRWD) is Buy with an average price target of $536.69.
What is the highest price target for CRWD?
The highest price target for CRWD is $706.00, set by Ellie Bagshaw at Arete Research on 2025-10-28.
What is the lowest price target for CRWD?
The lowest price target for CRWD is $120.00, set by Brad Reback at Stifel Nicolaus on 2022-11-30.
How many analysts cover CRWD?
69 analysts have issued ratings for CrowdStrike Holdings, Inc. in the past 12 months.
Is CRWD a buy or sell right now?
Based on 69 analyst ratings, CRWD has a consensus rating of Buy (2.22/5) with a +15.7% upside to the consensus target of $536.69.
What are the earnings estimates for CRWD?
Analysts estimate CRWD will report EPS of $4.87 for the period ending 2027-01-31, with revenue estimated at $5.91B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.